News | TCT | October 14, 2020

ACC and CRF Create the Martin B. Leon Center for Cardiovascular Transformation

Joint venture will fund research and education to eliminate health disparities, address impact of COVID and transform cardiovascular care

Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

October 14, 2020 — The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) are partnering to create the Martin B. Leon Center for Cardiovascular Transformation, a visionary endeavor designed to foster the best ideas, encourage innovative research, and ultimately deliver transformative solutions to some of the biggest cardiovascular care challenges.

The Leon Center is inspired by Martin Leon, M.D., FACC, and his legacy of innovation in cardiovascular care. Leon is a distinguished pioneer in interventional cardiology and the founder and director of Transcatheter Cardiovascular Therapeutics (TCT), a leading scientific symposium dedicated to interventional cardiovascular medicine.

“Designed to foster the best ideas, encourage innovative research, and ultimately deliver transformative and global solutions to some of the biggest challenges facing our profession and our patients – the Leon Center will be as transformational as the man for which it is named,” said CRF President and CEO Juan F. Granada, M.D. “CRF is excited to work with the ACC on this visionary endeavor that will build on the legacy already created by Dr. Martin Leon. The future of our profession and of our patients will be brighter because of this work together.”

Through the Leon Center’s four pillars, ACC and CRF will offer new advanced fellowships and clinical research grants focused on enhancing the pace of research in order to eradicate health disparities and transform cardiovascular care. The four pillars are:

   1. Addressing the impact of the pandemic on cardiovascular research and care.

   2. Programs to impact workforce diversity and team-based care.

   3. Workshops and forums to promote innovations in cardiovascular care.

   4. Patient advocacy and patient-centered education and research programs with a focus on underserved populations.

“To improve cardiovascular care and outcomes, we need visionary thinking and bold action. Through our joint work to create the Martin B. Leon Center for Cardiovascular Transformation, the ACC and CRF promise to deliver on that vision.” said ACC President Athena Poppas, M.D., FACC. “The biggest challenges require collaborative solutions, and through the Leon Center we are fostering diversity, innovative research and leadership as a springboard to a healthier future.”

For more information on the Leon Center, visit www.leoncenter.org.

Related Content

The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.20 annual meeting March 28-30, 2020, in Chicago. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.
Feature | ACC | April 09, 2020 | Dave Fornell, Editor
Here is the list of American College of Cardiology (ACC) practice-
ACC Cancels 2020 Conference Amid Coronavirus Concerns. #COVID19 #coronavirus #2019nCoV
Feature | ACC | March 09, 2020 | Dave Fornell, Editor
March 9, 2020 — Less than week after the American College of Cardiolog...
American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a